Health-care deal creates $6 billion company aiming to upend drug middlemen
John Tozzi | Bloomberg Eversana, a company that helps drugmakers sell their medicines, has acquired a smaller firm…
Genetic Study Suggests Ways to Catch Blood Cancer Earlier
Newswise — As we age, our cells replicate, and the DNA in these cells can acquire mistakes —…
Cancer’s Progress Detailed by 3D Genomic Maps
Newswise — Researchers have long known that cancer alters its genome as it evolves. What has been less…
News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments
FOR IMMEDIATE RELEASE Newswise — Harnessing the power of mRNA, a naturally occurring molecule that tells the body…
Cuban-born biotech honcho enters crowded NYC mayoral race seeking to upset Mamdani
He’s the anti-Mamdani. A Cuban-born biotech entrepreneur decided to make a longshot bid for NYC mayor because he…
IU Rare Disease Clinic Solves Toughest Medical Cold Cases
The IU Impact: We bring hope to families by providing answers for their ultra-rare medical mysteries and use…
AI Tools May Degrade Doctors’ Skills
In this week’s edition of The Prototype, we look at the risk of depending on AI to “think”…
Economic uncertainty stunts funding to San Diego startups
Investments in San Diego County startups decreased by 35% in the second quarter compared to a year ago,…
Century Therapeutics and Adaptimmune layoffs in Philly
Biotech in Philly Inside the Philadelphia Navy Yard, Adaptimmune opened its new U.S. headquarters in 2017. At the…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…